Tomko studies how cells build, maintain and utilize the proteasome in normal and disease states. His laboratory works on the scale of individual proteins up to whole cells, and integrates approaches spanning biochemistry, cell biology, genetics, proteomics, biophysics and pharmacology. Ultimately, his group aims to utilize the information gained from these basic studies of the proteasome to exploit its assembly and function for therapeutic benefit in human diseases.
Phone: (850) 645-1482
Topics: Cancer Pharmaceuticals Health + Medicine